Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2021 Filed Feb 18, 2021 21:12 UTC |
Martin SeanSVP and General Counsel
|
GrantCommon Stock, $1 par value | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001500332-21-000001 · edgar.xml · nonDerivative · entry 1 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,591 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:11 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantCommon Stock, $1 par value | 272 | $0.00 | $0.00 |
DisclosureSEC source: 0001779771-21-000002 · edgar.xml · nonDerivative · entry 5 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,126 F5 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:11 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantCommon Stock, $1 par value | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0001779771-21-000002 · edgar.xml · nonDerivative · entry 4 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,854 F4 · shares: Represents shares earned from the performance share unit award granted on September 4, 2018 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:11 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
Tax withholdingCommon Stock, $1 par value | 1,064 | $77.80 | $82,779.20 |
DisclosureSEC source: 0001779771-21-000002 · edgar.xml · nonDerivative · entry 3 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,387 F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:11 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantCommon Stock, $1 par value | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001779771-21-000002 · edgar.xml · nonDerivative · entry 2 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,451 F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:11 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantCommon Stock, $1 par value | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001779771-21-000002 · edgar.xml · nonDerivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,141 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC |
Frye AndrewSVP, President, APAC
|
GrantCommon Stock, $1 par value | 635 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 3 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 F3 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC |
Frye AndrewSVP, President, APAC
|
GrantCommon Stock, $1 par value | 2,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,354 F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC |
Frye AndrewSVP, President, APAC
|
GrantCommon Stock, $1 par value | 659 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,935 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:09 UTC |
Franzi CristianoSVP, President, EMEA
|
GrantCommon Stock, $1 par value | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001715790-21-000001 · edgar.xml · nonDerivative · entry 4 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,033 F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:09 UTC |
Franzi CristianoSVP, President, EMEA
|
Tax withholdingCommon Stock, $1 par value | 439 | $77.80 | $34,154.20 |
DisclosureSEC source: 0001715790-21-000001 · edgar.xml · nonDerivative · entry 3 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,307 F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:09 UTC |
Franzi CristianoSVP, President, EMEA
|
GrantCommon Stock, $1 par value | 2,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001715790-21-000001 · edgar.xml · nonDerivative · entry 2 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,746 F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:09 UTC |
Franzi CristianoSVP, President, EMEA
|
GrantCommon Stock, $1 par value | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0001715790-21-000001 · edgar.xml · nonDerivative · entry 1 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,924 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
GrantCommon Stock, $1 par value | 4,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001216761-21-000001 · edgar.xml · nonDerivative · entry 4 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,818 F4 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
Tax withholdingCommon Stock, $1 par value | 22,003 | $77.80 | $1,711,833.40 |
DisclosureSEC source: 0001216761-21-000001 · edgar.xml · nonDerivative · entry 3 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,283 F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2018, 2019, and 2020 as part of the 2018 PSUs. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
GrantCommon Stock, $1 par value | 20,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001216761-21-000001 · edgar.xml · nonDerivative · entry 2 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,286 F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
GrantCommon Stock, $1 par value | 5,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001216761-21-000001 · edgar.xml · nonDerivative · entry 1 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,126 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 5,293 | $0.00 Strike: $88.74 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 9 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Peter S. Hellman Dynasty Trust Disclosed balance after: 5,293 Underlying: Common Stock, $1 par value · 5,293 shares Expires 2030-05-03 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F4 · derivative.exercise_date: The options granted 05/05/2020, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 5,293 | $0.00 Strike: $88.74 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 8 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 5,293 shares Expires 2030-05-03 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F4 · derivative.exercise_date: The options granted 05/05/2020, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 7 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Peter S. Hellman Dynasty Trust Disclosed balance after: 6,138 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F3 · derivative.exercise_date: The options graned 05/07/2019, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 6,138 | $0.00 Strike: $76.69 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 6 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 6,138 shares Expires 2029-05-07 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F3 · derivative.exercise_date: The options graned 05/07/2019, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 6,437 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 5 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Peter S. Hellman Dynasty Trust Disclosed balance after: 6,437 Underlying: Common Stock, $1 par value · 6,437 shares Expires 2028-05-08 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F2 · derivative.exercise_date: The options are granted 05/08/2018, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| January 06, 2021 Filed Apr 7, 2021 22:55 UTC |
HELLMAN PETER SDirector
|
GiftStock Option (Right to Buy) · Derivative | 6,437 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001107468-21-000002 · edgar.xml · derivative · entry 4 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 6,437 shares Expires 2028-05-08 F1 · kind: Represents the bona fide gifts of options granted to Mr. Hellman by Baxter International Inc. ("BII") to the Peter S. Hellman Dynasty Trust for the benefit of Mr. Hellman's immediate family. F2 · derivative.exercise_date: The options are granted 05/08/2018, are fully vested, subject to the terms and conditions of the applicable grant. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 22:02 UTC |
Stevens BrianSVP, CAO and Controller
|
Tax withholdingCommon Stock, $1 par value | 749 | $76.32 | $57,163.68 |
DisclosureSEC source: 0001557559-20-000003 · edgar.xml · nonDerivative · entry 1 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,295 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 3, 2020 from the settlement of vested restricted stock units granted on December 3, 2018. Read SEC document |
| November 24, 2020 Filed Feb 17, 2021 01:44 UTC |
Chen Thomas FDirector
|
GiftCommon Stock, $1 par value | 9,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006779 · doc5.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Thomas F. Chen Grantor Irrevocable Trust Disclosed balance after: 9,174 F1 · kind: Represents the bona fide gift of the Issuer's Common Stock to the Thomas F. Chen Grantor Irrevocable Trust for the benefit of the Reporting Person's immediate family. Read SEC document |
| November 24, 2020 Filed Feb 17, 2021 01:44 UTC |
Chen Thomas FDirector
|
GiftCommon Stock, $1 par value | 9,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006779 · doc5.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,451 F1 · kind: Represents the bona fide gift of the Issuer's Common Stock to the Thomas F. Chen Grantor Irrevocable Trust for the benefit of the Reporting Person's immediate family. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:05 UTC |
Martin SeanSVP and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,001 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001500332-20-000004 · edgar.xml · derivative · entry 4 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,999 Underlying: Common Stock, $1 par value · 47,001 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Martin with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Martin. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:05 UTC |
Martin SeanSVP and General Counsel
|
SaleCommon Stock, $1 par value | 10,393 | $79.22 | $823,333.46 |
DisclosureSEC source: 0001500332-20-000004 · edgar.xml · nonDerivative · entry 3 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,640 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Martin with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Martin. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $ 78.94 through $79.76. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:05 UTC |
Martin SeanSVP and General Counsel
|
SaleCommon Stock, $1 par value | 36,608 | $78.52 | $2,874,460.16 |
DisclosureSEC source: 0001500332-20-000004 · edgar.xml · nonDerivative · entry 2 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,033 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Martin with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Martin. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $ 77.94 through $78.93. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:05 UTC |
Martin SeanSVP and General Counsel
|
Exercise / conversionCommon Stock, $1 par value | 47,001 | $50.77 | $2,386,240.77 |
DisclosureSEC source: 0001500332-20-000004 · edgar.xml · nonDerivative · entry 1 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Martin with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Martin. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:06 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
OtherDeferred Comp Plan Baxter Common Stock Fund · Derivative | 2,449 | $79.72 | $195,234.28 |
DisclosureSEC source: 0001779771-20-000003 · edgar.xml · derivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 2,449 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: Shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") were transferred to the Stable Income Fund the as the Fund was eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.exercise_date: Shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") were transferred to the Stable Income Fund the as the Fund was eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under the Baxter International Inc. and Subsidiaries Deferred Compensation Plan (the "Plan") were transferred to the Stable Income Fund the as the Fund was eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:07 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 310 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001262931-20-000004 · edgar.xml · derivative · entry 3 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 310 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Forsyth with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:07 UTC |
FORSYTH JOHN DDirector
|
SaleCommon Stock, $1 par value | 310 | $83.59 | $25,912.90 |
DisclosureSEC source: 0001262931-20-000004 · edgar.xml · nonDerivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,969 Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:07 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionCommon Stock, $1 par value | 310 | $31.26 | $9,690.60 |
DisclosureSEC source: 0001262931-20-000004 · edgar.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Forsyth with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:09 UTC |
GAVIN JAMES R IIIDirector
|
OtherDeferred Comp Plan Baxter Common Stock Fund · Derivative | 11,894 | $83.10 | $988,391.40 |
DisclosureSEC source: 0001220966-20-000003 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 11,894 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.exercise_date: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 03, 2020 Filed Feb 16, 2021 21:06 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,861 | $0.00 Strike: $28.97 | $0.00 |
DisclosureSEC source: 0001779771-21-000001 · edgar.xml · derivative · entry 3 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock, $1 par value · 1,861 shares Expires 2021-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Kunzler with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Ms. Kunzler. F4 · derivative.exercise_date: The options became exercisable in three equal annual installments beginning on March 4, 2012, the first anniversary of the grant date. Read SEC document |
| September 03, 2020 Filed Feb 16, 2021 21:06 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
SaleCommon Stock, $1 par value | 5,314 | $85.87 | $456,313.18 |
DisclosureSEC source: 0001779771-21-000001 · edgar.xml · nonDerivative · entry 2 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,775 F2 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Kunzler with respect to certain vested stock options and vested performance share units previously granted by BII to Ms. Kunzler. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $85.65 through $86.13. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| September 03, 2020 Filed Feb 16, 2021 21:06 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
Exercise / conversionCommon Stock, $1 par value | 1,861 | $28.97 | $53,913.17 |
DisclosureSEC source: 0001779771-21-000001 · edgar.xml · nonDerivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Kunzler with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Ms. Kunzler. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:13 UTC |
Borzi James WSVP, Global Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $85.55 | $0.00 |
DisclosureSEC source: 0001495559-20-000007 · edgar.xml · derivative · entry 2 Borzi James W · CIK 0001495559 · SVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $1 par value · 60,000 shares Expires 2030-08-30 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on September 1, 2021, the first anniversary of the grant date. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:13 UTC |
Borzi James WSVP, Global Supply Chain
|
GrantCommon Stock, $1 par value | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495559-20-000007 · edgar.xml · nonDerivative · entry 1 Borzi James W · CIK 0001495559 · SVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · shares: The reporting person received a grant of 12,000 restricted stock units which are scheduled to vest on September 1, 2022. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 20:13 UTC |
Franzi CristianoSVP, President, EMEA
|
Tax withholdingCommon Stock, $1 par value | 1,132 | $85.55 | $96,842.60 |
DisclosureSEC source: 0001715790-20-000004 · edgar.xml · nonDerivative · entry 1 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,036 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 1, 2020 from the settlement of vested restricted stock units granted on September 1, 2017. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:24 UTC |
HELLMAN PETER SDirector
|
OtherDeferred Comp Plan Baxter Common Stock Fund · Derivative | 1,660 | $82.89 | $137,597.40 |
DisclosureSEC source: 0001107468-20-000003 · edgar.xml · derivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 1,660 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investmnet alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.exercise_date: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investmnet alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investmnet alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:22 UTC |
Chen Thomas FDirector
|
OtherDeferred Comp Plan Baxter Common Stock Fund · Derivative | 3,386 | $82.89 | $280,665.54 |
DisclosureSEC source: 0001360147-20-000002 · edgar.xml · derivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,386 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.exercise_date: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person transferred shares from the Baxter Common Stock Fund (the "Fund") notional investment alternative deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,789 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · derivative · entry 6 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 10,789 shares Expires 2025-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,110 | $0.00 Strike: $39.83 | $0.00 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · derivative · entry 5 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,110 shares Expires 2024-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
SaleCommon Stock, $1 par value | 3,351 | $86.91 | $291,235.41 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 4 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,508 F3 · kind: Price reflects weighted average sales price. Range of prices for transactions are $ 86.82 through $86.96. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
SaleCommon Stock, $1 par value | 11,548 | $86.26 | $996,130.48 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,859 F2 · kind: Price reflects weighted average sales price. Range of prices for transactions are $ 85.80 through $86.80. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionCommon Stock, $1 par value | 10,789 | $37.50 | $404,587.50 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,110 | $39.83 | $163,701.30 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:00 UTC |
Accogli GiuseppeSVP, President, Americas
|
Exercise / conversionStock Option [Right to Buy) · Derivative | 62,388 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001678067-20-000003 · edgar.xml · derivative · entry 5 Accogli Giuseppe · CIK 0001678067 · SVP, President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,195 Underlying: Common Stock, $1 par value · 62,388 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Accogli with respect to certain vested stock options, restricted stock units, and performance share units previously granted by Baxter International Inc. to Mr. Accogli. F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2018, the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.